Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
04/2009
04/22/2009CN101412695A Quinoline derivatives having antimycotic activity and preparation thereof
04/22/2009CN100481571C Luminescent element material and luminescent element comprising the same
04/22/2009CN100480248C Malonamide derivatives as gamma-secretase inhibitors
04/21/2009US7521561 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma
04/21/2009US7521560 2-(5-aminocarbonyl-1H-imidazol-4-ylamino)-8-chloroquinoline; inhibit the IgE receptor signaling cascade; inhibit degranulation of mast and/or basophil cells; allergies
04/21/2009US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
04/21/2009US7521062 Thiosemicarbazones as anti-virals and immunopotentiators
04/21/2009CA2228038C 2(1h)-quinolone derivatives, their preparation and their use in therapy
04/21/2009CA2157855C Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation
04/16/2009WO2009048236A1 Method for the preparation of montelukast acid in ionic liquid medium
04/16/2009WO2009047568A2 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
04/16/2009WO2009021965A3 Substituted quinoline derivatives as h1 receptor antagonists
04/16/2009WO2007096889A3 Process for preparing montelukast and salts thereof
04/16/2009WO2007096875A3 Novel polymorphs of montelukast ammonium salts and processes for preparation therefor
04/16/2009US20090099367 Process for preparing a leukotriene antagonist
04/16/2009US20090099366 Process and intermediates for preparing integrase inhibitors
04/16/2009US20090099356 Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction
04/16/2009US20090099231 3-Sulfonylamino-Pyrrolidine-2-One Derivatives as Factor Xa Inhibitors
04/16/2009US20090099230 Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
04/16/2009US20090099106 Quinoline derivatives for modulating dna methylation
04/16/2009US20090096356 Light-emitting device material and light-emitting device
04/16/2009CA2702182A1 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
04/16/2009CA2701912A1 Method for the preparation of montelukast acid in ionic liquid medium
04/15/2009EP2046789A2 Labelled analogues of halobenzamides as radiopharmaceuticals
04/15/2009EP2046750A2 Process for the preparation of montelukast
04/15/2009EP1797881B1 Medicinal composition with improved stability and reduced gelation properties
04/15/2009EP1687257B1 Amino-substituted ethylamino beta2 adrenergic receptor agonists
04/15/2009EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
04/15/2009CN101407492A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same
04/15/2009CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
04/14/2009US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase
04/14/2009US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation
04/14/2009US7517910 Alkoxyphenylpropanoic acid derivatives
04/14/2009US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
04/14/2009CA2461432C Novel anthrapyridone compounds, water-base magenta ink compositions, and ink-jet recording process
04/14/2009CA2380980C Mutilin derivatives and their use as antibacterials
04/09/2009WO2008015703A3 Process for the preparation of montelukast and its salts thereof
04/09/2009US20090093636 Process for making montelukast and intermediates therefor
04/09/2009US20090093485 Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases
04/09/2009US20090092624 Antiinfective Flavononol Compounds and Methods of Use Thereof
04/09/2009US20090091252 Binaphthyl compound and organic light emitting element using the same
04/08/2009EP2045245A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof
04/08/2009EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase
04/08/2009EP2044939A1 Therapeutic agent for liver fibrosis
04/08/2009EP2044027A2 Fused bicyclic compounds interacting with the histamine h4 receptor
04/08/2009EP2044026A1 Method of treatment of glioma brain tumour
04/08/2009EP2044025A1 Quinolinone derivatives and their pharmaceutical compositions
04/08/2009EP2044018A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
04/08/2009EP2043993A2 Cyclopentane derivatives as antiglaucoma agents
04/08/2009EP1877364B1 Phenylacetylene derivatives having mglur5 receptor affinity
04/08/2009CN101405268A Amide derivatives and their application for the treatment of g protein related diseases
04/08/2009CN101405260A Amine derivatives
04/08/2009CN101402601A Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
04/08/2009CN100475787C Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
04/08/2009CN100475759C Novel aromatic compound and organic electroluminescnet element containing the same
04/07/2009US7514565 3,5-Difluoropyridines
04/07/2009US7514558 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary disease; asthma
04/07/2009US7514557 Hepatitis C; preparing 8-bromo-7-alkoxyquinolines 2-substituted with a hetercyclic ring having an amine, carbamate, amine or urea group an 4-substituted with a 3-prolineoxy- group or derivative; intermediates
04/07/2009US7514475 Benzylamine analogues
04/07/2009US7514451 1 -cyclopropyl-7- [3-cyclopropylaminomethyl-4-fluoro-1 -pyrrolidinyl]-6-fluoro -1 ,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid; bactericide; against drug-resistant bacteria and against gram-positive bacteria, such as MRSA, PRSP and VRE
04/07/2009US7514225 detecting drugs that inhibits the binding of macrophage migration inhibitory factor (MIF) to an antimacrophage migration inhibitor factor monoclonal or polyclonal antibody; drug screening
04/07/2009CA2276278C Amine compounds, their production and use
04/07/2009CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease
04/02/2009WO2009041904A1 Quinoline compounds having an activity against the gabab receptor
04/02/2009WO2009041521A1 Quinolone derivative
04/02/2009WO2009041072A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient
04/02/2009WO2009040377A2 Radiolabelled 1, 4 -dihydro-4 -oxo-quinoline 3-carboxylic acid derivatives for pet and spect imaging, and in-vitro detection of the gaba-a receptor
04/02/2009WO2009040290A1 Quinoline derivatives as 5ht5a receptor antagonists
04/02/2009WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
04/02/2009US20090088451 Quinolines
04/02/2009US20090088441 Quinoline Compounds
04/02/2009US20090088420 Compounds with hiv-1 integrase inhibitory activity and use thereof as anti-hiv/aids therapeutics
04/02/2009US20090084441 Dye-sensitized photoelectric conversion device
04/02/2009CA2700277A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
04/02/2009CA2700088A1 Quinolone derivative
04/02/2009CA2699697A1 Quinoline derivatives as 5ht5a receptor antagonists
04/01/2009EP2041069A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents
04/01/2009EP2040709A2 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
04/01/2009EP2040688A1 New cxcr2 inhibitors
04/01/2009EP1660431B1 Phenoxyacetic acid derivatives
04/01/2009EP1513530A4 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
04/01/2009EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors
04/01/2009CN101400655A Quinolone derivative or pharmaceutically acceptable salt thereof
04/01/2009CN101397355A Method for preparing molecular imprinting polymer capable of identifying oxytetracycline and enrofloxacin
03/2009
03/31/2009US7511157 Hepatitis C inhibitor dipeptide analogs
03/31/2009US7511144 Reverse hydroxamic acid derivatives
03/31/2009US7511063 High affinity quinoline-based kinase ligands
03/31/2009US7511062 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
03/31/2009US7511061 Triazoles as farnesyl transferase inhibitors
03/31/2009US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
03/26/2009WO2009038683A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
03/26/2009WO2008007211A8 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds
03/26/2009WO2005044802A3 Tetrahydro-quinolinylurea derivatives as vrl antagonists
03/26/2009US20090082396 5-aryl-4,5-dihydro-(1h)-pyrazolines as cannabinoid cb1 receptor agonists
03/26/2009US20090082395 Soluble epoxide hydrolase inhibitors
03/26/2009US20090082378 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the b2 adrenergic receptor
03/26/2009US20090079331 Compound and organic light-emitting device
03/26/2009CA2699292A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
03/25/2009EP2039736A1 Electroluminescent material containing an organic luminescent substance
03/25/2009EP2039677A1 Organic compounds containing heteroatoms and their use in ziegler-natta catalyst with single activation center
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 277